HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ziprasidone in bipolar disorder.

Abstract
Ziprasidone is a second-generation antipsychotic currently marketed for the treatment of schizophrenia and bipolar mania. It has a unique receptor profile that includes high-affinity antagonist activity at 5-hydroxytryptamine (5-HT) 2A, D2, 1D and 2C receptors, a potent agonist activity at 5-HT1A receptors and a relatively high affinity for the 5-HT and noradrenaline transporters. The efficacy of ziprasidone in bipolar mania (current episode, manic or mixed) has been well demonstrated in three placebo-controlled trials. In a three-arm controlled study, ziprasidone was shown to be efficacious in dysphoric mania, whereas haloperidol was comparable to placebo. Open-label treatment for up to 52 weeks supported the sustained efficacy of ziprasidone in bipolar disorder. Combined with lithium, ziprasidone has been shown to be efficacious as an augmenting agent in the acute treatment of mania, with sustained efficacy up to 1 year. Ziprasidone was very well tolerated by patients with bipolar disorder and did not cause increased weight, glucose or lipid levels.
AuthorsMarcio Versiani
JournalExpert opinion on pharmacotherapy (Expert Opin Pharmacother) Vol. 7 Issue 9 Pg. 1221-8 (Jun 2006) ISSN: 1744-7666 [Electronic] England
PMID16732708 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antimanic Agents
  • Antipsychotic Agents
  • Lithium Compounds
  • Piperazines
  • Thiazoles
  • ziprasidone
Topics
  • Antimanic Agents (administration & dosage, therapeutic use)
  • Antipsychotic Agents (administration & dosage, pharmacokinetics, therapeutic use)
  • Bipolar Disorder (drug therapy)
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Humans
  • Lithium Compounds (administration & dosage, therapeutic use)
  • Piperazines (administration & dosage, pharmacokinetics, therapeutic use)
  • Practice Guidelines as Topic
  • Thiazoles (administration & dosage, pharmacokinetics, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: